|
|
|
|
Universal Detection Technology in Deal with WellCrown International Resources to Distribute Bioweapons Detecti
(www.udetection.com)(OTCBB: UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats, and provider of counter-terrorism consulting and training services, reported today that...
|
|
|
Universal Detection Technology Working with U.S. Department of Commerce to Market Anthrax Detection Equipment
Universal Detection Technology (www.udetection.com) (OTCBB: UNDT), a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced today...
|
|
|
SLU to study smallpox vaccine in fight against bioterrorism
scientists plan to study the most effective way to administer an investigational vaccine for smallpox as part of efforts to protect Americans from a bioterrorism attack.Up to 240 volunteers are being recruited for the -funded study, which will be...
|
|
|
White House, Congress Get 'F' for Bioterrorism Preparedness
WASHINGTON - Nearly a decade after the U.S.was attacked with anthrax sent through the mail, the nation continues to lack the capabilities to rapidly respond to bioterrorism, a congressionally appointed commission said last week. Of the 17...
|
|
|
Aethlon Medical Discloses Hepatitis C (HCV) Treatment Publication
Aethlon Medical, Inc.(OTC Bulletin Board: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed that its Hemopurifier is the subject of a publication in the latest issue of the Journal of Blood...
|
|
|
Biodefense Industry Response to New WMD Report Card
Companies mentioned in this article: PharmAthene ANNAPOLIS, Md., Jan.26 /PRNewswire-USNewswire/ -- The following is a statement by David Wright, President and CEO of PharmAthene, regarding the Commission on the Prevention of Weapons of Mass Destruction...
|
|
|
Biodefense Industry Response to New WMD Report Card
ANNAPOLIS, Md., Jan.26 /PRNewswire-USNewswire/ -- The following is a statement by David Wright, President and CEO of PharmAthene, regarding the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism Report Card: Today's...
|
|
|
Aethlon Medical Discloses Hepatitis-C (HCV) Treatment Publication
SAN DIEGO (Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b) About Aethlon Medical Aethlon Medical, Inc.creates diagnostic and therapeutic device solutions for infectious disease and cancer. , Our lead product, the Hemopurifier, is the...
|
|
|
Research Indicates Llama Proteins Could Play a Vital Role in the War on Terror
Category: Research News Font Size A highly sensitive means of detecting the seven types of botulinum neurotoxins (BoNTs) simultaneously has been developed by scientists at the Southwest Foundation for Biomedical Research (SFBR).The BoNT-detecting substances...
|
|
|
Llama proteins a vital piece in the war on terror?
Scientists at the Southwest Foundation for Biomedical Research (SFBR) have for the first time developed a highly sensitive means of detecting the seven types of botulinum neurotoxins (BoNTs) simultaneously.The BoNT-detecting substances are antibodiesproteins...
|
|
|
Llama proteins could play a vital role in the war on terror
Scientists at the (SFBR) have for the first time developed a highly sensitive means of detecting the seven types of botulinum neurotoxins (BoNTs) simultaneously.The BoNT-detecting substances are antibodies --proteins made by the body to fight diseases--found...
|
|
|
Llama proteins could play a vital role in the war on terror
Scientists at the (SFBR) have for the first time developed a highly sensitive means of detecting the seven types of botulinum neurotoxins (BoNTs) simultaneously.The BoNT-detecting substances are antibodies --proteins made by the body to fight diseases--found...
|
|
|
Llama Proteins Could Play a Vital Role in the War on Terror by Detecting World's 'Most Poisonous Poisons'
The BoNT-detecting substances are antibodies --proteins made by the body to fight diseases--found in llamas.BoNT are about 100 billion times more toxic than cyanide, and collectively, they are the only toxins in the federal Centers for Disease Control and...
|
|
|
Israel Taps SIGA Technologies' ST-246(R) to Combat Smallpox in Simulated Bioterror Attack
NEW YORK, Jan.19, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. , a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced that it was contacted to arrange an emergency mock acquisition of its...
|
|
|
Response Biomedical (RPBIF.OB) Sees Revenues Nearly Doubling In 2009 - Penny Stock To Watch
Watch Family & What's New: Community: : January 14, 2010 3:10:31 AM EST News Story Response Biomedical (.OB) Sees Revenues Nearly Doubling In 2009 - Penny Stock To Watch Monday January 11, 2010 09:20:00 EST (RTTNews) - On-site diagnostic tests maker...
|
|
|
Response Biomedical (RPBIF.OB) Sees Revenues Nearly Doubling In 2009 - Penny Stock To Watch
(RTTNews) - On-site diagnostic tests maker Response Biomedical Corp.(RPBIF.OB: News ) forecast revenues of $10 million for 2009, nearly double the $5.876 million the company reported in 2008, attributing the revenue growth to mainly its partners, Roche...
|
|
|
Pharmaceutical firm attracts investments and partnerships: Technology used for several ailments [Detroit Free
10An Ann Arbor-based biopharmaceutical company continues to attract investments, grants and partners, including a new licensing agreement with a large drug company to help it develop and sell the most advanced product in its pipeline.Under the...
|
|
|
Pharmaceutical firm attracts investments and partnerships: Technology used for several ailments [Detroit Free
10--An Ann Arbor-based biopharmaceutical company continues to attract investments, grants and partners, including a new licensing agreement with a large drug company to help it develop and sell the most advanced product in its pipeline.Under the...
|
|
|
Pharmaceutical firm attracts investments and partnerships
An Ann Arbor-based biopharmaceutical company continues to attract investments, grants and partners, including a new licensing agreement with a large drug company to help it develop and sell the most advanced product in its pipeline.Under the GlaxoSmithKline...
|
|
|
NanoBio to Present Data on its Novel Nanoemulsion-based Vaccine Adjuvant Platform at the World Influenza Congr
- NanoBio Corporation announced today that its CEO and Founder, James R.Baker, Jr., M.D., will present new data from studies of its nanoemulsion-based adjuvant platform during the World Influenza Congress, taking place from December 7-9, 2009 in Brussels,...
|
